First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Sets New 1-Year High – Should You Buy?

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBTGet Free Report) reached a new 52-week high during trading on Monday . The company traded as high as GBX 1,633.60 ($21.21) and last traded at GBX 1,600.90 ($20.79), with a volume of 0 shares traded. The stock had previously closed at GBX 1,609.10 ($20.89).

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Down 0.7 %

The firm’s 50 day moving average price is GBX 1,580.01 and its two-hundred day moving average price is GBX 1,512.33. The firm has a market capitalization of £4.70 billion and a PE ratio of -1,445.45. The company has a quick ratio of 9.27, a current ratio of 9.42 and a debt-to-equity ratio of 0.04.

About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation

(Get Free Report)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.

Featured Articles

Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.